Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
株式のランク #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
株価
$0.5099
最終同期: 2024-10-15
時価総額
$7.60M
変化(1日)
2.02%
変化(1年)
0.00%
US
取引 Anew Medical, Inc. (WENA)

カテゴリー

Anew Medical, Inc.(WENA)の発行済株式数
June 2024 時点の発行済株式数 15.05M
Anew Medical, Inc. の最新の財務報告および株価によると、現在の発行済株式数は 15.05M です。December 2022 の終わりには、同社は 14.91M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Anew Medical, Inc.(WENA)の発行済株式数の履歴(2021 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 15.05M 54.33%
2023 9.76M -34.55%
2022 14.91M 14.85%
2021 12.98M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数
253.90M 1,586.52%
US
62.19M 313.07%
NL
- -
CH
- -
KR
0.00 -100.00%
BE